0000899243-20-010626.txt : 20200409 0000899243-20-010626.hdr.sgml : 20200409 20200409203502 ACCESSION NUMBER: 0000899243-20-010626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200408 FILED AS OF DATE: 20200409 DATE AS OF CHANGE: 20200409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McIntyre Gail Frances CENTRAL INDEX KEY: 0001492646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 20785819 MAIL ADDRESS: STREET 1: C/O FURIEX PHARMACEUTICALS, INC. STREET 2: 3900 PARAMOUNT PARKWAY, SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aravive, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: RIVER OAKS TOWER STREET 2: 3730 KIRBY DRIVE, SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 BUSINESS PHONE: 936-355-1910 MAIL ADDRESS: STREET 1: RIVER OAKS TOWER STREET 2: 3730 KIRBY DRIVE, SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 FORMER COMPANY: FORMER CONFORMED NAME: Versartis, Inc. DATE OF NAME CHANGE: 20110223 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-08 0 0001513818 Aravive, Inc. ARAV 0001492646 McIntyre Gail Frances C/O ARAVIVE, INC., RIVER OAKS TOWER, 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 1 1 0 0 CEO and President Stock Option 6.16 2020-04-08 4 A 0 80000 0.00 A 2020-05-08 2030-04-07 Common stock 80000 80000 D These options vest pro rata on a monthly basis over four (4) years commencing on May 8, 2020, the one month anniversary of the grant date. /s/ Abel Svitavsky, Attorney-in-fact 2020-04-09